New Paper: A Targeted, Low-Throughput Compound Screen in a Drosophila Model of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD)

April 26, 2023

Check out our latest paper:

A Targeted, Low-Throughput Compound Screen in a Drosophila Model of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD) Dyson A, Ryan M, Garg S, Evans DG, Baines RA. eNeuro, DOI: 10.1523/ENEURO.0461-22.2023